METHOD OF TREATING TRIFACIAL NERVE NEURALGIA Russian patent published in 2012 - IPC A61B18/02 A61H39/06 A61K31/4152 A61K31/4406 A61K31/495 A61K31/5513 A61K31/7048 A61P25/02 

FIELD: medicine.

SUBSTANCE: present invention refers to medicine, namely neurology, and may be used for treating patients with trifacial nerve neuralgia. For this purpose, perivascular fibres of radial artery and trigeminal nerve branch exit points are exposed to low-temperature reflex radiation. It is combined with two exposures of the perivascular fibres of radial artery from a miniapproach in a lower one-third of forearm to a cryocautery device of a tip diameter of 2 mm for 10 seconds at temperature minus 165°C. Then, the trigeminal nerve branch exit points are locally exposed to the cryocautery device of the tip diameter of 2 mm for 30 seconds at temperature minus 160°C. Further, from the second day following the local low-temperature exposure, an integrated drug-induced therapy is prescribed. For this purpose, detralex 1 capsule is introduced twice a day, and nicoshpan is introduced 1 tablet 3 times a day for two weeks. Suture release is followed by the two-week introduction of grandaxin 0.05 in the morning, spasgan 1 tablet in the afternoon, atarax 1/2 tablets for the night.

EFFECT: method provides reducing length of treatment and number of unsatisfactory clinical outcomes with substantial compensation of pain syndrome with formation of prolonged remission of a pathological process ensured by improved peripheral blood flow and correction of vegetative disorders supporting pain syndrome.

2 ex